1. Home
  2. PSTX vs CVLG Comparison

PSTX vs CVLG Comparison

Compare PSTX & CVLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTX
  • CVLG
  • Stock Information
  • Founded
  • PSTX 2014
  • CVLG 1986
  • Country
  • PSTX United States
  • CVLG United States
  • Employees
  • PSTX N/A
  • CVLG N/A
  • Industry
  • PSTX Biotechnology: Biological Products (No Diagnostic Substances)
  • CVLG Trucking Freight/Courier Services
  • Sector
  • PSTX Health Care
  • CVLG Industrials
  • Exchange
  • PSTX Nasdaq
  • CVLG Nasdaq
  • Market Cap
  • PSTX 909.4M
  • CVLG 763.1M
  • IPO Year
  • PSTX 2020
  • CVLG 1994
  • Fundamental
  • Price
  • PSTX $9.45
  • CVLG $54.46
  • Analyst Decision
  • PSTX Hold
  • CVLG Strong Buy
  • Analyst Count
  • PSTX 3
  • CVLG 2
  • Target Price
  • PSTX $9.00
  • CVLG $69.50
  • AVG Volume (30 Days)
  • PSTX 2.7M
  • CVLG 43.6K
  • Earning Date
  • PSTX 11-07-2024
  • CVLG 01-21-2025
  • Dividend Yield
  • PSTX N/A
  • CVLG 0.81%
  • EPS Growth
  • PSTX N/A
  • CVLG N/A
  • EPS
  • PSTX N/A
  • CVLG 3.02
  • Revenue
  • PSTX $150,858,000.00
  • CVLG $1,128,130,000.00
  • Revenue This Year
  • PSTX $131.92
  • CVLG $5.29
  • Revenue Next Year
  • PSTX N/A
  • CVLG $6.37
  • P/E Ratio
  • PSTX N/A
  • CVLG $18.27
  • Revenue Growth
  • PSTX 203.18
  • CVLG 0.22
  • 52 Week Low
  • PSTX $1.87
  • CVLG $43.00
  • 52 Week High
  • PSTX $9.58
  • CVLG $61.54
  • Technical
  • Relative Strength Index (RSI)
  • PSTX 86.05
  • CVLG 39.21
  • Support Level
  • PSTX $9.35
  • CVLG $57.24
  • Resistance Level
  • PSTX $9.56
  • CVLG $58.12
  • Average True Range (ATR)
  • PSTX 0.10
  • CVLG 1.46
  • MACD
  • PSTX -0.17
  • CVLG -0.61
  • Stochastic Oscillator
  • PSTX 56.67
  • CVLG 11.64

About PSTX Poseida Therapeutics Inc.

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

About CVLG Covenant Logistics Group Inc.

Covenant Logistics Group Inc together with its wholly-owned subsidiaries offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight and Warehousing. Expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. Managed Freight segment includes brokerage services and TMS. Warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function. Majority of revenue is generated from expedited segment.

Share on Social Networks: